Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
HSR26-240: Patient-Reported Outcomes, Race and Ethnicity in Gastric Cancer Clinical Trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 01, 2026
The Role of Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Carcinoma in the Era of Emerging Systemic Therapy: A Retrospective Cohort Study.
Journal: Cancers
Published: April 08, 2026
HSR26-240: Patient-Reported Outcomes, Race and Ethnicity in Gastric Cancer Clinical Trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Urinary Diversion After Cystectomy for Bladder Cancer.
Journal: JAMA oncology
Published: December 04, 2025
Historical Perspective of HER2 Testing and Treatment in Prostate Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: December 04, 2025
CaboPoint and the Future of Renal Cell Carcinoma Trials: Sequencing, Biomarkers, and Strategy.
Journal: European urology
Published: October 05, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.
Journal: Cancers
Published: October 08, 2024
Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies.
Journal: Current oncology reports
Published: December 11, 2023
Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 31, 2023
Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series.
Journal: JCO precision oncology
Published: February 22, 2023
Last Updated: 09/26/2026